Pensatech Pharma GmbH (founded in Berlin, Germany in 2012) is a knowledge- and science- driven research and development company with a comprehensive suite of known and innovative drug delivery technologies. We focus on designing, developing and advancing dosage forms for new and existing drugs.

Our expertise includes oral modified-release systems such as granules, pellets, minitablets, osmotic and matrix tablets, as well as parenteral formulations including aqueous and oily solutions, micro- and nanosuspensions, microparticles, implants, liposomes, biodegradable polymeric and lipid carriers, and lyophilized products.

We also focus on local drug delivery, particularly ocular and topical applications, and offer a range of bioavailability and solubility enhancement technologies, including emulsions, micro- and nanosuspensions, solid dispersions, hot-melt extrusion, and spray-dried dispersions.

Our portfolio further covers stability improvement, formulations for highly potent APIs and cytotoxics, high-dose drug delivery, and the development of classical dosage forms such as tablets, capsules, coatings, solutions, suspensions, and gels.